This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Allschil, CH (2016)
- Allschwil, CH (2018 - 2021)
Company Filing History:
Years Active: 2016-2021
Title: Innovations of Jean-Marc Alfred Schlaeppi
Introduction
Jean-Marc Alfred Schlaeppi is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of immunology, particularly through his work on Interleukin-18 (IL-18) binding molecules. With a total of 3 patents to his name, Schlaeppi's innovations are paving the way for advancements in therapeutic and diagnostic applications.
Latest Patents
Schlaeppi's latest patents focus on IL-18 binding molecules. IL-18 plays a crucial role in both innate and acquired immunity. The bioactivity of IL-18 is negatively regulated by the IL-18 binding protein (IL18BP), which inhibits its biological activity by forming a complex with free IL-18. The inventions disclosed by Schlaeppi include binding molecules, particularly antibodies or fragments, that specifically bind IL-18 without interacting with the IL-18/IL-18BP complex. These binding molecules have potential applications as therapeutic agents for treating IL-18-related autoimmune and inflammatory diseases, as well as diagnostic tools for measuring IL-18 levels.
Career Highlights
Jean-Marc Schlaeppi is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further explore the therapeutic potential of his inventions. Schlaeppi's research has contributed to a deeper understanding of IL-18's role in various diseases, enhancing the prospects for innovative treatments.
Collaborations
Some of Schlaeppi's notable coworkers include Michael Otto Bardroff and Barbara Brannetti. Their collaborative efforts have likely enriched the research environment and fostered innovative solutions in the field of immunology.
Conclusion
Jean-Marc Alfred Schlaeppi's contributions to the field of immunology through his patents on IL-18 binding molecules highlight his role as a significant inventor. His work not only advances scientific understanding but also opens new avenues for therapeutic and diagnostic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile